CannPal Animal Therapeutics Limited announced the appointment of Dr. Margaret Curtis as Head of Clinical Development and R&D for the company. Prior to CannPal, Dr. Curtis most recent role was as the U.S-based Director of Global Dairy Product Development at Elanco Animal Health. In addition to overseeing CannPal's pharmaceutical drug candidates, Dr. Curtis will also be involved in the development of the Company's nutraceutical pipeline which the company intends to pursue in 2018.